First Trust Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.49M | Buy |
62,160
+33,209
| +115% | +$3.47M | 0.01% | 1239 |
|
|
2025
Q1 | $3.38M | Sell |
28,951
-25,629
| -47% | -$2.99M | ﹤0.01% | 1521 |
|
|
2024
Q4 | $4.62M | Buy |
54,580
+11,488
| +27% | +$972K | ﹤0.01% | 1403 |
|
|
2024
Q3 | $3.87M | Buy |
43,092
+16,501
| +62% | +$1.48M | ﹤0.01% | 1459 |
|
|
2024
Q2 | $2.14M | Sell |
26,591
-38,921
| -59% | -$3.13M | ﹤0.01% | 1679 |
|
|
2024
Q1 | $5.23M | Sell |
65,512
-4,397
| -6% | -$351K | 0.01% | 1265 |
|
|
2023
Q4 | $5.56M | Buy |
+69,909
| New | +$5.56M | 0.01% | 1204 |
|